MIRA Pharmaceuticals, Inc. (MIRA)
0.8654
+0.03
(+3.98%)
USD |
NASDAQ |
Sep 21, 16:00
0.8654
0.00 (0.00%)
After-Hours: 20:00
MIRA Pharmaceuticals Debt to Equity Ratio : 0.00 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.00 |
| March 31, 2026 | 0.00 |
| December 31, 2025 | 0.00 |
| September 30, 2025 | 0.00 |
| June 30, 2025 | 0.00 |
| March 31, 2025 | 0.00 |
| December 31, 2024 | 0.00 |
| September 30, 2024 | 0.00 |
| June 30, 2024 | 0.00 |
| Date | Value |
|---|---|
| March 31, 2024 | 0.0004 |
| December 31, 2023 | 0.0012 |
| September 30, 2023 | 0.0134 |
| June 30, 2023 | 1.613 |
| March 31, 2023 | -0.2015 |
| December 31, 2022 | -0.8239 |
| September 30, 2022 | |
| June 30, 2022 | |
| March 31, 2022 | 0.1724 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Resonate Blends, Inc. | -1.103 |
| Breakthrough Chemistry, Inc. | 0.2335 |
| Kaya Holdings, Inc. | -- |
| Cardiac Biotech Solutions, Inc. | -0.2375 |
| Earth Science Tech, Inc. | 0.0481 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 8.203M |
| Total Liabilities (Quarterly) | 0.0408M |
| Shareholders Equity (Quarterly) | 8.162M |
| Current Ratio | 200.19 |